Log In
Print
BCIQ
Print
Print this Print this
 

PNAG Vaccine (AV0318)

  Manage Alerts
Collapse Summary General Information
Company Alopexx Vaccine LLC
DescriptionVaccine based on deacetylated poly-N-acetyl glucosamine (PNAG)
Molecular Target Poly-N-acetyl glucosamine (PNAG)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsPrevent bacterial infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today